Revenue for 2025 is projected to be between $115 million and $125 million, with expectations of console growth and recurring revenue expansion. Gross margins for 2025 are expected to be in the high 30 ...

Outset Medical (NASDAQ:OM) has observed the following analyst ratings within the last quarter: These 6 analysts have an average price target of $13.17 versus the current price of Outset Medical at ...

A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

SAN JOSE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...

Outset said that it has resumed distribution of TabloCart with prefiltration and has product available to ship to customers in the United States. “With the FDA’s clearance of TabloCart with ...

Secures New Debt Financing of up to $125M Maturing in 2030 with Plans to Retire $200M in Prior Debt In addition, Outset has entered into a credit agreement and guaranty with a fund managed by ...

Outset Medical, Inc. has appointed Renee Gaeta as its new Chief Financial Officer, effective immediately, succeeding Nabeel Ahmed who is leaving for other opportunities. Gaeta brings extensive ...

When Outset Medical announced in June that it would be pausing shipments of its portable Tablo hemodialysis systems to new at-home users, the company’s stock plunged to an all-time low. Just a few ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener The latest update ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, a commercial-stage company delivering first-of-its-kind technology into the growing global dialysis market, today announced the appointment of two ...